Clinical Study | Office of Clinical Research

Phase II Trial Of Post-Operative Or Definitive Concurrent Radiation And Cetuximab For Locally Advanced Cutaneous Squamous Cell Carcinoma Of The Head

Posted Date: May 15, 2019

Investigator: Vinita Takiar
Specialties:
Type of Study: Drug

Surgery followed by radiation can often stop head and neck skin tumors from growing. However, cancer can recur or spread. Cetuximab may delay or prevent tumor growth and is approved by the FDA for head and neck cancer. This study examines the addition of cetuximab to standard therapy.

Criteria:

Eligible Patients Must Have Locally Advanced Cutaneous Squamous Cell Carcinoma Of The Head And Neck.

Keywords:

Cutaneous, Head And Neck Cancer, Locally Advanced, Squamous Cell Carcin, Uchn-12-001

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List